97455-65-7Relevant academic research and scientific papers
6-Substituted nicotinic acid analogues, potent inhibitors of CAIII, used as therapeutic candidates in hyperlipidemia and cancer
Mohammad, Haneen K.,Alzweiri, Muhammed H.,Khanfar, Mohammad A.,Al-Hiari, Yusuf M.
, p. 1397 - 1404 (2017)
Nicotinic acid has been reported as a potential inhibitor of carbonic anhydrase III enzyme. Carbonic anhydrase III (CAIII) is an emerging new pharmacological target for the management of dyslipidemia and cancer progression. The activity of 6-substituted n
CARBINOL DERIVATIVES HAVING CYCLIC LINKER
-
Page/Page column 22, (2010/03/31)
[Object] To provide a novel LXRβ agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A carbinol compound represented by the following general formula (I) or salt thereof, or their solvate.
6-n-Alkoxy-3-Pyridinecarboxaldehydes: New Intermediates to Liquid Crystals. Properties of Some Derivatives.
Barbera, J.,Melendez, E.,Romero, P.,Serrano, J. L.
, p. 259 - 268 (2007/10/02)
The synthesis of new intermediates to liquid crystals, a series of 6-n-alkoxy-3-pyridinecarboxaldehydes is described.The mesomorphic properties of their precursors, the 6-n-alkoxy-3-pyridinecarboxylic acids are reported.Some derivatives of the carboxaldeh
